Genesis Healthcare, Inc.
GENN · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $3,906 | $4,566 | $4,977 | $5,374 |
| % Growth | -14.4% | -8.3% | -7.4% | – |
| Cost of Goods Sold | $2,256 | $2,485 | $2,787 | $3,037 |
| Gross Profit | $1,650 | $2,081 | $2,190 | $2,337 |
| % Margin | 42.2% | 45.6% | 44% | 43.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $541 | $532 | $279 | $315 |
| SG&A Expenses | $541 | $532 | $279 | $318 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $595 | $594 | $1,980 | $170 |
| Operating Income | $1,056 | $1,487 | $210 | $183 |
| % Margin | 27% | 32.6% | 4.2% | 3.4% |
| Other Income/Exp. Net | -$1,162 | -$1,478 | -$585 | -$1,152 |
| Pre-Tax Income | -$107 | $9 | -$375 | -$970 |
| Tax Expense | -$4 | $2 | -$2 | -$10 |
| Net Income | -$59 | $15 | -$235 | -$579 |
| % Margin | -1.5% | 0.3% | -4.7% | -10.8% |
| EPS | -0.53 | 0.14 | -2.33 | -6.15 |
| % Growth | -478.6% | 106% | 62.1% | – |
| EPS Diluted | -0.53 | 0.1 | -2.33 | -6.15 |
| Weighted Avg Shares Out | 112 | 107 | 101 | 94 |
| Weighted Avg Shares Out Dil | 112 | 165 | 101 | 94 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $135 | $180 | $464 | $499 |
| Depreciation & Amortization | $108 | $123 | $221 | $256 |
| EBITDA | $136 | $313 | $310 | -$214 |
| % Margin | 3.5% | 6.9% | 6.2% | -4% |